Meeting
2015 ASCO Annual Meeting
A phase III trial of short-term androgen deprivation therapy in intermediate-risk prostate cancer treated with radiotherapy.
Authors
Abdenour Nabid
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada
Abdenour Nabid , Nathalie Carrier , Eric Vigneault , Luis Souhami , Céline Lemaire , Marc-André Brassard , Boris Bahoric , Robert Archambault , François Vincent , Thu-Van Nguyen-Huynh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary (Prostate) Cancer
Track
Genitourinary Cancer
Sub Track
Prostate Cancer
Clinical Trial Registration Number
#NCT00223145
Citation
J Clin Oncol 33, 2015 (suppl; abstr 5019)
DOI
10.1200/jco.2015.33.15_suppl.5019
Abstract #
5019
Poster Bd #
11
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Is there a relationship between testosterone levels at the end of short-term androgen deprivation therapy and outcomes in intermediate risk prostate cancer? Prospective data from a phase III trial.
First Author: Abdenour Nabid
Poster
2019 Genitourinary Cancers Symposium
Optimizing the use of androgen deprivation therapy in men with localized intermediate risk prostate cancer in the era of modern dose-escalated radiation therapy.
First Author: Sagar Anil Patel
Poster
2018 ASCO Annual Meeting
Timing of androgen deprivation therapy for prostate cancer patients after radiation: Planned combined analysis of two randomized phase 3 trials.
First Author: Andrew Loblaw
Poster
2011 ASCO Annual Meeting
Phase III trial comparing long-term versus short-term androgen deprivation combined with high-dose radiotherapy for localized prostate cancer: GICOR protocol DART01/05.
First Author: A. Zapatero